In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Check the time stamp on this data. Updated AI-Generated Signals for Novavax Inc. (NVAX) available here: NVAX.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

In the most recent trading session, Novavax (NVAX) closed at $12.80, indicating a -0.85% shift from the previous trading day.

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

Sep. 25, 2024 — A new study could change the way scientists view microbial processes in the deep ocean. The unexpected findings expand our understanding of the impacts of climate change ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

The S&P 500 was essentially flat on Tuesday, Sept. 17, 2024, closing less than 0.1% higher on the last day before the Fed's ...

Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...